Kostas Dimas

883 total citations
18 papers, 748 citations indexed

About

Kostas Dimas is a scholar working on Molecular Biology, Cancer Research and Organic Chemistry. According to data from OpenAlex, Kostas Dimas has authored 18 papers receiving a total of 748 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Organic Chemistry. Recurrent topics in Kostas Dimas's work include Sesquiterpenes and Asteraceae Studies (5 papers), Plant Toxicity and Pharmacological Properties (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Kostas Dimas is often cited by papers focused on Sesquiterpenes and Asteraceae Studies (5 papers), Plant Toxicity and Pharmacological Properties (4 papers) and Pharmacological Receptor Mechanisms and Effects (3 papers). Kostas Dimas collaborates with scholars based in Greece, United States and France. Kostas Dimas's co-authors include Costas Demetzos, Anastasia Karioti, Helen Skaltsa, Sophia Hatziantoniou, Μάριος Μαρσέλος, Dimitra Angelopoulou, Vasiliki Saroglou, George B. Foscolos, Sofia Mitaku and Thomas Mavromoustakos and has published in prestigious journals such as Journal of Medicinal Chemistry, International Journal of Pharmaceutics and Pharmacological Research.

In The Last Decade

Kostas Dimas

18 papers receiving 729 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kostas Dimas Greece 16 429 175 169 158 129 18 748
Dilip M. Mondhe India 20 535 1.2× 105 0.6× 69 0.4× 185 1.2× 116 0.9× 30 1.1k
Lisa I. Pilkington New Zealand 16 354 0.8× 124 0.7× 38 0.2× 312 2.0× 110 0.9× 102 849
Sang‐Un Choi South Korea 19 509 1.2× 157 0.9× 58 0.3× 318 2.0× 64 0.5× 44 917
Bianka Siewert Austria 22 714 1.7× 163 0.9× 66 0.4× 299 1.9× 84 0.7× 70 1.3k
Toyonobu Usuki Japan 19 444 1.0× 138 0.8× 67 0.4× 374 2.4× 88 0.7× 110 1.2k
Kishore K. Chiruvella India 18 751 1.8× 285 1.6× 82 0.5× 269 1.7× 107 0.8× 36 1.3k
Miroslav Kvasnica Czechia 21 1.1k 2.5× 554 3.2× 100 0.6× 319 2.0× 59 0.5× 48 1.7k
Mitsumasa Haruna Japan 22 855 2.0× 416 2.4× 210 1.2× 279 1.8× 78 0.6× 55 1.3k
Gousia Chashoo India 19 383 0.9× 98 0.6× 50 0.3× 407 2.6× 45 0.3× 39 899
Barbara Bednarczyk–Cwynar Poland 16 500 1.2× 95 0.5× 39 0.2× 171 1.1× 36 0.3× 53 730

Countries citing papers authored by Kostas Dimas

Since Specialization
Citations

This map shows the geographic impact of Kostas Dimas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kostas Dimas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kostas Dimas more than expected).

Fields of papers citing papers by Kostas Dimas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kostas Dimas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kostas Dimas. The network helps show where Kostas Dimas may publish in the future.

Co-authorship network of co-authors of Kostas Dimas

This figure shows the co-authorship network connecting the top 25 collaborators of Kostas Dimas. A scholar is included among the top collaborators of Kostas Dimas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kostas Dimas. Kostas Dimas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Papanastasiou, Ioannis, George B. Foscolos, Andrew Tsotinis, et al.. (2012). New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity. Medicinal Chemistry. 8(4). 569–586. 19 indexed citations
2.
Dimas, Kostas, et al.. (2012). Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo. Cancer Science. 103(10). 1826–1832. 17 indexed citations
3.
Papanastasiou, Ioannis, George B. Foscolos, Andrew Tsotinis, et al.. (2012). Synthesis, σ1, σ2-receptors binding affinity and antiproliferative action of new C1-substituted adamantanes. Bioorganic & Medicinal Chemistry. 20(10). 3323–3331. 21 indexed citations
4.
Papanastasiou, Ioannis, George B. Foscolos, Andrew Tsotinis, et al.. (2012). New Adamantane Phenylalkylamines with σ-Receptor Binding Affinity and Anticancer Activity, Associated with Putative Antagonism of Neuropathic Pain. Journal of Medicinal Chemistry. 55(22). 10241–10261. 22 indexed citations
5.
Saroglou, Vasiliki, Anastasia Karioti, Kostas Dimas, et al.. (2010). Sesquiterpene Lactones from Anthemis melanolepis and Their Antibacterial and Cytotoxic Activities. Prediction of Their Pharmacokinetic Profile. Journal of Natural Products. 73(2). 242–246. 28 indexed citations
7.
Hatziantoniou, Sophia, et al.. (2005). Labdane-type diterpenes: thermal effects on phospholipid bilayers, incorporation into liposomes and biological activity. Chemistry and Physics of Lipids. 138(1-2). 1–11. 32 indexed citations
8.
Dimas, Kostas, et al.. (2005). Doxorubicin–PAMAM dendrimer complex attached to liposomes: Cytotoxic studies against human cancer cell lines. International Journal of Pharmaceutics. 302(1-2). 29–38. 90 indexed citations
9.
Saroglou, Vasiliki, Anastasia Karioti, Costas Demetzos, Kostas Dimas, & Helen Skaltsa. (2005). Sesquiterpene Lactones from Centaurea spinosa and Their Antibacterial and Cytotoxic Activities. Journal of Natural Products. 68(9). 1404–1407. 67 indexed citations
10.
Hatziantoniou, Sophia, et al.. (2004). Liposomal Formulations from Phospholipids of Greek Almond Oil. Properties and Biological Activity. Zeitschrift für Naturforschung C. 59(5-6). 330–334. 11 indexed citations
11.
Kolocouris, Antonios, Kostas Dimas, Christophe Pannecouque, et al.. (2002). New 2-(1-adamantylcarbonyl)pyridine and 1-acetyladamantane thiosemicarbazones–thiocarbonohydrazones: cell growth inhibitory, antiviral and antimicrobial activity evaluation. Bioorganic & Medicinal Chemistry Letters. 12(5). 723–727. 55 indexed citations
12.
Skaltsa, Helen, et al.. (2002). Bioactive Sesquiterpene Lactones from Centaurea Species and their Cytotoxic/Cytostatic Activity Against Human Cell Lines in vitro. Planta Medica. 68(7). 649–652. 65 indexed citations
13.
Demetzos, Costas, et al.. (2001). Cytotoxic and Anti-Inflammatory Activity of Labdane and cis-Clerodane Type Diterpenes. Planta Medica. 67(7). 614–618. 58 indexed citations
14.
Dimas, Kostas, et al.. (2000). Biological activity of myricetin and its derivatives against human leukemic cell lines in vitro. Pharmacological Research. 42(5). 475–478. 30 indexed citations
15.
Dimas, Kostas, et al.. (2000). CYTOTOXIC ACTIVITY OF KAEMPFEROL GLYCOSIDES AGAINST HUMAN LEUKAEMIC CELL LINES IN VITRO. Pharmacological Research. 41(1). 83–86. 47 indexed citations
16.
Dimas, Kostas, et al.. (1999). Cytotoxic and antiproliferative effects of heptaacetyltiliroside on human leukemic cell lines. Leukemia Research. 23(11). 1021–1033. 11 indexed citations
17.
Dimas, Kostas, et al.. (1999). The effect of sclareol on growth and cell cycle progression of human leukemic cell lines. Leukemia Research. 23(3). 217–234. 59 indexed citations
18.
Dimas, Kostas, et al.. (1998). Cytotoxic Activity of Labdane Type Diterpenes Against Human Leukemic Cell Linesin vitro. Planta Medica. 64(3). 208–211. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026